Related Experiment Video

Updated: Jul 25, 2025

Author Spotlight: Advancing Rapid Detection of Respiratory Pathogens Using Microfluidic Chip
06:11

Author Spotlight: Advancing Rapid Detection of Respiratory Pathogens Using Microfluidic Chip

Published on: March 29, 2024

1.9K

Identify Drug-Resistant Pathogens in Patients with Community-Acquired Pneumonia

Francesco Amati1,2, Francesco Bindo2,3, Anna Stainer1,2

  • 1Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, Pieve Emanuele, 20072 Milan, Italy.

Advances in Respiratory Medicine
|June 27, 2023
PubMed

Insights

Broad-spectrum antibiotics are increasingly used for community-acquired pneumonia (CAP) due to concerns about drug-resistant pathogens (DRP). However, their overuse may lead to adverse events and increased costs, necessitating a review of identification approaches and outcomes.

Area of Science:

  • Infectious Diseases
  • Clinical Pharmacy
  • Epidemiology

Background:

  • Increased use of broad-spectrum antibiotics for community-acquired pneumonia (CAP) over 15 years.
  • Rising incidence of drug-resistant pathogens (DRP) like MRSA and Pseudomonas aeruginosa in CAP patients.
  • Variability in DRP incidence based on local ecology, healthcare systems, and countries.

Purpose of the Study:

  • Analyze methods for identifying DRP in CAP.
  • Evaluate outcomes associated with broad-spectrum antibiotic use in CAP.
  • Assess adverse events linked to broad-spectrum antibiotic therapy for CAP.

Main Methods:

  • Review of published research on DRP identification in CAP.
  • Analysis of epidemiological data on DRP incidence.
  • Examination of studies on broad-spectrum antibiotic outcomes and adverse events.

Main Results:

  • Evidence suggests DRP incidence in CAP varies significantly by region.
  • Overuse of broad-spectrum antibiotics is linked to increased costs, hospital stay, adverse events, and resistance.
  • The effectiveness of broad-spectrum antibiotics in improving CAP outcomes is questioned.

Conclusions:

  • Current approaches to identifying DRP in CAP require careful consideration of local epidemiology.
  • Prudent use of broad-spectrum antibiotics is crucial to mitigate risks of resistance, adverse events, and healthcare costs.
  • Further research is needed to optimize antibiotic strategies for CAP management.
Keywords:
broad-spectrum antibioticscommunity-acquired pneumoniadrug-resistant pathogens

More Related Videos

Isolation and Identification of Waterborne Antibiotic-Resistant Bacteria and Molecular Characterization of their Antibiotic Resistance Genes08:58

Isolation and Identification of Waterborne Antibiotic-Resistant Bacteria and Molecular Characterization of their Antibiotic Resistance Genes

Published on: March 3, 2023

6.6K
Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.1K

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
278
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
388
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
46
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
284
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
214